AU:ENP Stock Latest News
Company AnnouncementsEntropy Neurodynamics Boosts Director Equity Through Share-Based Fees2w agoENP
Company AnnouncementsEntropy Neurodynamics Issues Director Fee Shares, Confirms Regulatory Compliance2w agoENP
Company AnnouncementsEntropy Neurodynamics Issues Equity to Directors in Lieu of Cash Fees2w agoENP
Company AnnouncementsEntropy Neurodynamics posts 2026 AGM materials and streamlines investor communications3w agoENP
Company AnnouncementsEntropy Neurodynamics Sets Date for 2026 AGM and Director Nomination Deadline1M agoENP
Company AnnouncementsEntropy Neurodynamics Reports Durable 12-Week Gains in BED Trial of Psychedelic Therapy TRP-88031M agoENPCompany AnnouncementsEntropy Neurodynamics to Showcase Psilocin Program in Investor Webinar2M agoENP
Company AnnouncementsEntropy Neurodynamics Narrows Annual Loss as Revenue Jumps 30%2M agoENP
Company AnnouncementsEntropy Neurodynamics Plans U.S. Phase 2 Trial Pitting Psychedelic Therapy Against Lexapro2M agoENP
Company AnnouncementsEntropy Neurodynamics Seeks ASX Quotation for 1 Million New Shares2M agoENP
Company AnnouncementsEntropy Neurodynamics Seeks Trading Halt Ahead of Key U.S. Phase 2 Trial Update2M agoENP
Company AnnouncementsEntropy Neurodynamics secures BioCina for global-scale manufacturing of IV psilocin therapy2M agoENPCompany AnnouncementsEntropy Neurodynamics Issues Director Fee Shares, Confirms Regulatory Compliance2M agoENP
Company AnnouncementsEntropy Neurodynamics Issues New Shares in Lieu of Directors’ Fees2M agoENP
Company AnnouncementsTryp Therapeutics Showcases World-First Binge Eating Trial in Psychedelic Neuropsychiatry2M agoENP
Company AnnouncementsEntropy Neurodynamics wins approval for multi-indication TRP-8803 basket trial2M agoENP
Company AnnouncementsEntropy Neurodynamics Halts Trading Ahead of Key Ethics Approval Update3M agoENP
Company AnnouncementsEntropy Neurodynamics strengthens governance with new joint company secretary3M agoENPCompany AnnouncementsEntropy Neurodynamics Secures First Clinical Validation for IV Psilocin Platform3M agoENP
Company AnnouncementsEntropy Neurodynamics Posts Breakthrough Phase 2 Results for IV Psilocin in Binge Eating Disorder3M agoENP


